Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1981 Aug;40:93–100. doi: 10.1289/ehp.814093

The carcinogenicity of arsenic.

G Pershagen
PMCID: PMC1568809  PMID: 7023936

Abstract

A carcinogenic role of inorganic arsenic has been suspected for nearly a century. Exposure to inorganic arsenic compounds occurs in some occupational groups, e.g., among smelter workers and workers engaged in the production and use of arsenic containing pesticides. Substantial exposure can also result from drinking water in certain areas and the use of some drugs. Tobacco and wine have had high As concentrations due to the use of arsenic containing pesticides. Inorganic arsenic compounds interfere with DNA repair mechanisms and an increased frequency of chromosomal aberrations have been observed among exposed workers and patients. Epidemiological data show that inorganic arsenic exposure can cause cancer of the lung and skin. The evidence of an etiologic role of arsenic for angiosarcoma of the liver is highly suggestive; however, the association between arsenic and cancer of other sites needs further investigation. No epidemiological data are available on exposure to organic arsenic compounds and cancer. Animal carcinogenicity studies involving exposure to various inorganic and organic arsenic compounds by different routes have been negative, with the possible exception of some preliminary data regarding lung cancer and leukemia. Some studies have indicated an increased mortality from lung cancer in populations living near point emission sources of arsenic into the air. The role of arsenic cannot be evaluated due to lack of exposure data. Epidemiological data suggest that the present WHO standard for drinking water (50 micrograms As/l.) provides only a small safety margin with regard to skin cancer.

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARONI C., VAN ESCHG, SAFFIOTTI U. CARCINOGENESIS TESTS OF TWO INORGANIC ARSENICALS. Arch Environ Health. 1963 Dec;7:668–674. doi: 10.1080/00039896.1963.10663598. [DOI] [PubMed] [Google Scholar]
  2. Blejer H. P., Wagner W. Inorganic arsenic--ambient level approach to the control of occupational cancerigenic exposures. Ann N Y Acad Sci. 1976;271:179–186. doi: 10.1111/j.1749-6632.1976.tb23107.x. [DOI] [PubMed] [Google Scholar]
  3. Borgoño J. M., Vicent P., Venturino H., Infante A. Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plant. Environ Health Perspect. 1977 Aug;19:103–105. doi: 10.1289/ehp.19-1637404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Braman R. S., Foreback C. C. Methylated forms of arsenic in the environment. Science. 1973 Dec 21;182(4118):1247–1249. doi: 10.1126/science.182.4118.1247. [DOI] [PubMed] [Google Scholar]
  5. Byron W. R., Bierbower G. W., Brouwer J. B., Hansen W. H. Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. Toxicol Appl Pharmacol. 1967 Jan;10(1):132–147. doi: 10.1016/0041-008x(67)90135-4. [DOI] [PubMed] [Google Scholar]
  6. Crecelius E. A. Arsenite and arsenate levels in wine. Bull Environ Contam Toxicol. 1977 Aug;18(2):227–230. doi: 10.1007/BF01686071. [DOI] [PubMed] [Google Scholar]
  7. Deng J. S., How S. W. Comparison of the fine structure of basal cell carcinomas in ordinary patients and patients with chronic arsenicalism. Taiwan Yi Xue Hui Za Zhi. 1977 Sep;76(9):685–692. [PubMed] [Google Scholar]
  8. FLUHARTY A. L., SANADI D. R. On the mechanism of oxidative phosphorylation. II. Effects of arsenite alone and in combination with 2,3-dimercaptopropanol. J Biol Chem. 1961 Oct;236:2772–2778. [PubMed] [Google Scholar]
  9. Gabor S., Coldea V. Some aspects of the environmental exposure to arsenic in Romania. Environ Health Perspect. 1977 Aug;19:107–108. doi: 10.1289/ehp.7719107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HUEPER W. C., PAYNE W. W. Experimental studies in metal carcinogenesis. Chromium, nickel, iron, arsenic. Arch Environ Health. 1962 Nov;5:445–462. doi: 10.1080/00039896.1962.10663311. [DOI] [PubMed] [Google Scholar]
  11. Harrington J. M., Middaugh J. P., Morse D. L., Housworth J. A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska. Am J Epidemiol. 1978 Nov;108(5):377–385. doi: 10.1093/oxfordjournals.aje.a112635. [DOI] [PubMed] [Google Scholar]
  12. Holland R. H., Acevedo A. R. Current status of arsenic in American cigarettes. Cancer. 1966 Sep;19(9):1248–1250. doi: 10.1002/1097-0142(196609)19:9<1248::aid-cncr2820190910>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  13. Ishinishi N., Kodama Y., Nobutomo K., Hisanaga A. Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung. Environ Health Perspect. 1977 Aug;19:191–196. doi: 10.1289/ehp.7719191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ivankovic S., Eisenbrand G., Preussmann R. Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic-containing pesticide mixture formerly used in vineyards. Int J Cancer. 1979 Dec 15;24(6):786–788. doi: 10.1002/ijc.2910240615. [DOI] [PubMed] [Google Scholar]
  15. Kanisawa M., Schroeder H. A. Life term studies on the effect of trace elements on spontaneous tumors in mice and rats. Cancer Res. 1969 Apr;29(4):892–895. [PubMed] [Google Scholar]
  16. Kroes R., van Logten M. J., Berkvens J. M., de Vries T., van Esch G. J. Study on the carcinogenicity of lead arsenate and sodium arsenate and on the possible synergistic effect of diethylnitrosamine. Food Cosmet Toxicol. 1974 Oct;12(5-6):671–679. doi: 10.1016/0015-6264(74)90238-7. [DOI] [PubMed] [Google Scholar]
  17. Lander J. J., Stanley R. J., Sumner H. W., Boswell D. C., Aach R. D. Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite). Gastroenterology. 1975 Jun;68(6):1582–1586. [PubMed] [Google Scholar]
  18. Ledet A. E., Duncan J. R., Buck W. B., Ramsey F. K. Clinical, toxicological, and pathological aspects of arsanilic acid poisoning in swine. Clin Toxicol. 1973;6(3):439–457. doi: 10.3109/15563657308990543. [DOI] [PubMed] [Google Scholar]
  19. Lee A. M., Fraumeni J. F., Jr Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst. 1969 Jun;42(6):1045–1052. [PubMed] [Google Scholar]
  20. Liebscher K., Smith H. Essential and nonessential trace elements. A method of determining whether an element is essential or nonessential in human tissue. Arch Environ Health. 1968 Dec;17(6):881–890. doi: 10.1080/00039896.1968.10665346. [DOI] [PubMed] [Google Scholar]
  21. Mabuchi K., Lilienfeld A. M., Snell L. M. Lung cancer among pesticide workers exposed to inorganic arsenicals. Arch Environ Health. 1979 Sep-Oct;34(5):312–320. doi: 10.1080/00039896.1979.10667423. [DOI] [PubMed] [Google Scholar]
  22. Milner J. E. The effect of ingested arsenic on methylcholanthrene-induced skin tumors in mice. Arch Environ Health. 1969 Jan;18(1):7–11. doi: 10.1080/00039896.1969.10665366. [DOI] [PubMed] [Google Scholar]
  23. Morton W., Starr G., Pohl D., Stoner J., Wagner S., Weswig D. Skin cancer and water arsenic in Lane County, Oregon. Cancer. 1976 May;37(5):2523–2532. doi: 10.1002/1097-0142(197605)37:5<2523::aid-cncr2820370545>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  24. Natusch D. F., Wallace J. R., Evans C. A., Jr Toxic trace elements: preferential concentration in respirable particles. Science. 1974 Jan 18;183(4121):202–204. doi: 10.1126/science.183.4121.202. [DOI] [PubMed] [Google Scholar]
  25. Nelson K. W. Industrial contributions of arsenic to the environment. Environ Health Perspect. 1977 Aug;19:31–34. doi: 10.1289/ehp.771931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nelson W. C., Lykins M. H., Mackey J., Newill V. A., Finklea J. F., Hammer D. I. Mortality among orchard workers exposed to lead arsenate spray: a cohort study. J Chronic Dis. 1973 Feb;26(2):105–118. doi: 10.1016/0021-9681(73)90009-x. [DOI] [PubMed] [Google Scholar]
  27. Newman J. A., Archer V. E., Saccomanno G., Kuschner M., Auerbach O., Grondahl R. D., Wilson J. C. Histologic types of bronchogenic carcinoma among members of copper-mining and smelting communities. Ann N Y Acad Sci. 1976;271:260–268. doi: 10.1111/j.1749-6632.1976.tb23120.x. [DOI] [PubMed] [Google Scholar]
  28. Nishioka H. Mutagenic activities of metal compounds in bacteria. Mutat Res. 1975 Jun;31(3):185–189. doi: 10.1016/0165-1161(75)90088-6. [DOI] [PubMed] [Google Scholar]
  29. Oppenheim J. J., Fishbein W. N. Induction of chromosome breaks in cultured normal human leukocytes by potassium arsenite, hydroxyurea and related compounds. Cancer Res. 1965 Aug;25(7):980–985. [PubMed] [Google Scholar]
  30. Osswald H., Goerttler K. Leukosen bei der Maus nach diaplacentarer und postnataler Arsenik-Applikation. Verh Dtsch Ges Pathol. 1971;55:289–293. [PubMed] [Google Scholar]
  31. Ott M. G., Holder B. B., Gordon H. L. Respiratory cancer and occupational exposure to arsenicals. Arch Environ Health. 1974 Nov;29(5):250–255. doi: 10.1080/00039896.1974.10666582. [DOI] [PubMed] [Google Scholar]
  32. PRIER R. F., NEES P. O., DERSE P. H. The toxicity of an organic arsenical, 3-nitro-4-hydroxyphenylarsonic acid. II. Chronic toxicity. Toxicol Appl Pharmacol. 1963 Jul;5:526–542. doi: 10.1016/0041-008x(63)90024-3. [DOI] [PubMed] [Google Scholar]
  33. Paton G. R., Allison A. C. Chromosome damage in human cell cultures induced by metal salts. Mutat Res. 1972 Nov;16(3):332–336. doi: 10.1016/0027-5107(72)90166-2. [DOI] [PubMed] [Google Scholar]
  34. Pearson E. F., Pounds C. A. A case involving the administration of known amounts of arsenic and its analysis in hair. J Forensic Sci Soc. 1971 Oct;11(4):229–234. doi: 10.1016/s0015-7368(71)70666-5. [DOI] [PubMed] [Google Scholar]
  35. Pershagen G., Elinder C. G., Bolander A. M. Mortality in a region surrounding an arsenic emitting plant. Environ Health Perspect. 1977 Aug;19:133–137. doi: 10.1289/ehp.7719133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Petres J., Baron D., Hagedorn M. Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies. Environ Health Perspect. 1977 Aug;19:223–227. doi: 10.1289/ehp.7719223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pinto S. S., Enterline P. E., Henderson V., Varner M. O. Mortality experience in relation to a measured arsenic trioxide exposure. Environ Health Perspect. 1977 Aug;19:127–130. doi: 10.1289/ehp.7719127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pinto S. S., Henderson V., Enterline P. E. Mortality experience of arsenic-exposed workers. Arch Environ Health. 1978 Nov-Dec;33(6):325–331. doi: 10.1080/00039896.1978.10667356. [DOI] [PubMed] [Google Scholar]
  39. Popper H., Thomas L. B., Telles N. C., Falk H., Selikoff I. J. Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol. 1978 Aug;92(2):349–376. [PMC free article] [PubMed] [Google Scholar]
  40. ROE F. J., SALAMAN M. H. Further tests for tumour-initiating activity: N, N-di-(2-chloroethyl)-p-aminophenylbutyric acid (CB1348) as an initiator of skin tumour formation in the mouse. Br J Cancer. 1956 Jun;10(2):363–378. doi: 10.1038/bjc.1956.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. ROSSET M. Arsenical keratoses associated with carcinomas of the internal organs. Can Med Assoc J. 1958 Mar 15;78(6):416–419. [PMC free article] [PubMed] [Google Scholar]
  42. ROTH F. Arsen, Leber, Tumoren; Hämangioendotheliom. Z Krebsforsch. 1957;61(5):468–503. [PubMed] [Google Scholar]
  43. ROTH F. Uber den Bronchialkrebs arsengeschädigter Winzer. Virchows Arch Pathol Anat Physiol Klin Med. 1958;331(2):119–137. doi: 10.1007/BF00955191. [DOI] [PubMed] [Google Scholar]
  44. Rossman T., Meyn M. S., Troll W. Effects of sodium arsenite on the survival of UV-irradiated Escherichia coli: inhibition of a recA-dependent function. Mutat Res. 1975 Nov;30(2):157–162. [PubMed] [Google Scholar]
  45. Schrauzer G. N., Ishmael D. Effects of selenium and of arsenic on the genesis of spontaneous mammary tumors in inbred C3H mice. Ann Clin Lab Sci. 1974 Nov-Dec;4(6):441–447. [PubMed] [Google Scholar]
  46. Schrauzer G. N., White D. A., McGinness J. E., Schneider C. J., Bell L. J. Arsenic and cancer: effects of joint administration of arsenite and selenite on the genesis of mammary adenocarcinoma in inbred female C3H/St mice. Bioinorg Chem. 1978 Sep;9(3):245–253. doi: 10.1016/s0006-3061(78)80005-2. [DOI] [PubMed] [Google Scholar]
  47. Smith T. J., Crecelius E. A., Reading J. C. Airborne arsenic exposure and excretion of methylated arsenic compounds. Environ Health Perspect. 1977 Aug;19:89–93. doi: 10.1289/ehp.771989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Smith T. J., Eatough D. J., Hansen L. D., Mangelsen N. F. The chemistry of sulfur and arsenic in airborne copper smelter particulates. Bull Environ Contam Toxicol. 1976 Jun;15(6):651–659. doi: 10.1007/BF01685613. [DOI] [PubMed] [Google Scholar]
  49. Tokudome S., Kuratsune M. A cohort study on mortality from cancer and other causes among workers at a metal refinery. Int J Cancer. 1976 Mar 15;17(3):310–317. doi: 10.1002/ijc.2910170306. [DOI] [PubMed] [Google Scholar]
  50. Tseng W. P. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977 Aug;19:109–119. doi: 10.1289/ehp.7719109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Vahter M., Norin H. Metabolism of 74As-labeled trivalent and pentavalent inorganic arsenic in mice. Environ Res. 1980 Apr;21(2):446–457. doi: 10.1016/0013-9351(80)90049-3. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES